Vitamin D levels modulate LL-37, influencing UTI frequency and reflux nephropathy in VUR children.
Background
Vesicoureteral Reflux (VUR) is a common pediatric condition predisposing children to urinary tract infections (UTIs), which can lead to reflux nephropathy (RN) and permanent kidney damage. Current management focuses on preventing UTIs, but understanding underlying immune factors is crucial. Vitamin D is known to play a significant role in innate immunity by regulating the expression of antimicrobial peptides (AMPs) like LL-37. This study investigates how Vitamin D status influences innate immune responses and contributes to the pathophysiology of RN in children with VUR, addressing a gap in understanding its specific role in this vulnerable population.
Study Design
This cross-sectional observational study included 25 pediatric patients with VUR, a subgroup from a larger cohort. Researchers assessed patients' Vitamin D status by measuring serum levels. They then correlated these levels with the frequency of recurrent UTIs and the presence of reflux nephropathy (RN). Additionally, the study explored the relationship between Vitamin D levels and urinary LL-37, NGAL, and IL-6 levels, which served as markers of innate immune function and kidney injury. No specific intervention or dose of Vitamin D was administered, as it was an observational design.
Results
Serum Vitamin D levels in the cohort ranged from 10.7 to 123.2 ng/mL, with a mean of 39.5 ng/mL. The study identified 12% of patients with Vitamin D deficiency and 20% with insufficient levels. Patients experiencing more than five episodes of acute pyelonephritis (APNs) exhibited lower mean Vitamin D levels, classified as insufficient at 27.3 ng/mL. While patients with reflux nephropathy (RS) had a lower mean Vitamin D level (30.51 ng/mL) compared to those without (41.23 ng/mL), this difference was not statistically significant (p = 0.39). No significant associations were found between Vitamin D and urinary IL-6 or NGAL levels. However, a robust and clinically significant finding emerged:
A strong positive correlation was observed between Vitamin D and urinary
LL-37/creatinine (r = 0.78,r2 = 0.61), indicating that higher Vitamin D levels are associated with increasedLL-37secretion, a key antimicrobial peptide.
Key Findings
- Mean serum Vitamin D level was 39.5 ng/mL in pediatric VUR patients.
- 12% of patients had Vitamin D deficiency and 20% had insufficient levels.
- Patients with >five APNs had lower mean Vitamin D levels (27.3 ng/mL).
- No significant difference in Vitamin D levels between RS and non-RS patients (
p = 0.39). - Strong positive correlation between Vitamin D and urinary
LL-37/creatinine (r = 0.78,r2 = 0.61).
Why It Matters
This study highlights that optimizing Vitamin D status could be a simple, non-invasive strategy to potentially reduce UTI frequency and mitigate reflux nephropathy progression in children with VUR. The strong correlation with LL-37 suggests a direct mechanism through which Vitamin D enhances innate immune defense in the urinary tract. For clinicians, this implies that routine Vitamin D screening and supplementation, if indicated, might become a valuable adjunct to standard care for VUR patients. While this observational study doesn't provide specific dosing protocols, it lays the groundwork for future interventional trials to determine if Vitamin D supplementation can indeed improve outcomes and reduce the burden of UTIs and kidney damage in this vulnerable pediatric population.
vitamin-d
vesicoureteral-reflux
uti
reflux-nephropathy
innate-immunity
ll-37